IL22 and ulcerative colitis: Studies have also found that in the context of chronic inflammation or inflammatory bowel diseases (such as Crohn’s disease and ulcerative colitis), ILC3s may continuously secrete IL-22 to try to balance ongoing tissue damage and repair needs.